Omalizumab Efficacy in Patients With Refractory Nasal Polyps
Clinical trial NCT05405478 · UNKNOWN
Trial details
- NCT number
- NCT05405478
- Sponsor
- Shiraz University of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-01
- Primary completion
- 2022-12-23
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.